Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

Status:
Not yet recruiting

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

The purpose of this study is to explore the efficacy and safety of CsA ophthalmic gel in the treatment of moderate to severe dry eye disease .

Phase 3

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Ophthalmic Solutions